In a recent study, we demonstrated that NSG-A2 mice engrafted with human hematopoiesis via the transplantation of CD34+ human HSCs recapitulated the case-fatality ratios of ebolaviruses in humans after experimental infection (13). This evidence concerns the gene CD34 and infection.